Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis

Neurology

Volumn 76, Issue 15, 2011, Pages 1316-1321

  Otto, C ^a   Oltmann, A ^a   Stein, A ^a   Frenzel, K ^a   Schroeter, J ^a   Habbel, P ^a   Gartner B ^b   Hofmann, J ^a   Ruprecht, K ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIBODY; HERPES SIMPLEX VIRUS ANTIBODY; HERPES ZOSTER IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MEASLES ANTIBODY; RUBELLA ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNE RESPONSE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; BRAIN DISEASES; COHORT STUDIES; DEMYELINATING DISEASES; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; LYMPHOPROLIFERATIVE DISORDERS; MALE; MEASLES; MIDDLE AGED; MULTIPLE SCLEROSIS; SPINAL CORD; TRANSPLANTS; YOUNG ADULT;

EID: 79954605834     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318215286d     Document Type: Article

References (24)

1. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis: part I: the role of infection. Ann Neurol 2007;61:288-299. (Pubitemid 46676728)
2. Ascherio A, Munger KL. Epstein-Barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 2010;5:271-277.
3. Serafini B, Rosicarelli B, Franciotta D, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007;204:2899-2912. (Pubitemid 350179559)
4. Cepok S, Zhou D, Srivastava R, et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005; 115:1352-1360. (Pubitemid 40629055)
5. Reiber H, Peter JB. Cerebrospinal fluid analysis: diseaserelated data patterns and evaluation programs. J Neurol Sci 2001;184:101-122. (Pubitemid 32178265)
6. Jacobi C, Lange P, Reiber H. Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing pa- nencephalitis, herpes simplex encephalitis and multiple sclerosis: discrimination between microorganism-driven and polyspecific immune response. J Neuroimmunol 2007;187:139-146. (Pubitemid 47001538)
7. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991;37:1153-1160. (Pubitemid 21925939)
8. Cinque P, Cleator GM, Weber T, Monteyne P, Sindic CJ, van Loon AM. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report: The EU Concerted Action on Virus Meningitis and Encephalitis. J Neurol Neurosurg Psychiatry 1996;61:339-345. (Pubitemid 26355772)
9. Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 1998;4:111-117. (Pubitemid 28410034)
10. Jaquiery E, Jilek S, Schluep M, et al. Intrathecal immune responses to EBV in early MS. Eur J Immunol 2010;40: 878-887.
11. Pohl D, Rostasy K, Jacobi C, et al. Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis. J Neurol 2010;257:212-216.
12. Rand KH, Houck H, Denslow ND, Heilman KM. Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis. J Neurol Sci 2000;173:32-39. (Pubitemid 30081773)
13. Sargsyan SA, Shearer AJ, Ritchie AM, et al. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 2010;74:1127-1135.
14. Castellazzi M, Tamborino C, Cani A, et al. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis. Mult Scler 2010; 16:883-887.
15. Nociti V, Frisullo G, Marti A, et al. Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis. J Neuroimmunol 2010;225:149-152.
16. Conrad AJ, Chiang EY, Andeen LE, et al. Quantitation of intrathecal measles virus IgG antibody synthesis rate: subacute sclerosing panencephalitis and multiple sclerosis. J Neuroimmunol 1994;54:99-108. (Pubitemid 24312628)
17. Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol 2004;138:46-54. (Pubitemid 38850248)
18. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-846. (Pubitemid 41746873)
19. Montalban X, Tintore M, Swanton J, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology 2010;74:427-434.
20. Teunissen CE, Petzold A, Bennett JL, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 2009;73:1914-1922.
21. Cavaliere R, Petroni G, Lopes MB, Schiff D. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer 2010;116:863-870.
22. Peferoen LA, Lamers F, Lodder LN, et al. Epstein-Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 2010;133:e137.
23. Willis SN, Stadelmann C, Rodig SJ, et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009;132:3318-3328.
24. Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010;67:824-830.